Leading Analyst Firm recognizes Evolutionary MDM Solutions
Menlo Park, CA – November 7, 2012
Semarchy, the Data Convergence Company and leading provider of Evolutionary MDM Solutions, announced today that is has been recognized by Gartner, Inc. in the Magic Quadrant for Master Data Management of Customer Data Solutions [1].
“Having Gartner reference our Evolutionary approach and solutions for Master Data Management is an important milestone for us,” said Salah Kamel, CEO and Founder of Semarchy. “We believe this mention is confirmation of our mission to help organizations drive value from their consolidated master data across all their business domains.”
Semarchy has seen strong momentum in the MDM space where an increasing number of corporations have acknowledged and adopted the company’s innovative approach and technology.
“We continue to innovate and execute on our product roadmap. With the recent launch of Convergence for MDM 2.0, we have delivered a truly (r)evolutionary product that will enhance our market position”, added Kamel.
Tweet This: @Gartner recognizes @Semarchy as an MDM vendor https://goo.gl/4ymrw
[1] Gartner, Inc., Magic Quadrant for Master Data Management of Customer Data Solutions, John Radcliffe and Bill O’Kane, October 18, 2012.
About Semarchy
Semarchy (www.semarchy.com) enables organizations to consolidate and enrich master data across all their business domains. Semarchy Convergence for MDM is the only Evolutionary MDM platform specifically designed to reduce Master Data Management (MDM) project timescales and costs, for simple as well as complex master data projects.
About the Gartner Magic Quadrant
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.